Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
warfarin nuclear receptor subfamily 1 group i member 2 small molecule NA drugbank Venous Thromboembolism[MeSHID:D054556]
Heart Valves[MeSHID:D006351]
Cerebrovascular accident[MeSHID:D020521]
Rheumatism[MeSHID:D012216]
Atrial Fibrillation[MeSHID:D001281]
Mitral Valve[MeSHID:D008943]
Myocardial Infarction[MeSHID:D009203]
Thromboembolism[MeSHID:D013923]
Pulmonary Embolism[MeSHID:D011655]
Collagen Diseases[MeSHID:D003095]
Transient Cerebral Ischemia[MeSHID:D002546]
Recurrence (disease attribute)[MeSHID:D012008]
Thrombosis[MeSHID:D013927]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved unknown
warfarin vitamin k epoxide reductase complex 1 NA Successful target TTD , DGIDB Venous Thromboembolism[MeSHID:D054556]
Heart Valves[MeSHID:D006351]
Cerebrovascular accident[MeSHID:D020521]
Rheumatism[MeSHID:D012216]
Atrial Fibrillation[MeSHID:D001281]
Mitral Valve[MeSHID:D008943]
Myocardial Infarction[MeSHID:D009203]
Thromboembolism[MeSHID:D013923]
Pulmonary Embolism[MeSHID:D011655]
Collagen Diseases[MeSHID:D003095]
Transient Cerebral Ischemia[MeSHID:D002546]
Recurrence (disease attribute)[MeSHID:D012008]
Thrombosis[MeSHID:D013927]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 26.68 approved inhibitor
warfarin vitamin k epoxide reductase complex subunit 1 small molecule NA drugbank , DGIDB Venous Thromboembolism[MeSHID:D054556]
Heart Valves[MeSHID:D006351]
Cerebrovascular accident[MeSHID:D020521]
Rheumatism[MeSHID:D012216]
Atrial Fibrillation[MeSHID:D001281]
Mitral Valve[MeSHID:D008943]
Myocardial Infarction[MeSHID:D009203]
Thromboembolism[MeSHID:D013923]
Pulmonary Embolism[MeSHID:D011655]
Collagen Diseases[MeSHID:D003095]
Transient Cerebral Ischemia[MeSHID:D002546]
Recurrence (disease attribute)[MeSHID:D012008]
Thrombosis[MeSHID:D013927]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 26.68 approved inhibitor
warfarin vitamin k epoxide reductase complex 1 NA Successful target TTD , DGIDB Venous Thromboembolism[MeSHID:D054556]
Heart Valves[MeSHID:D006351]
Cerebrovascular accident[MeSHID:D020521]
Rheumatism[MeSHID:D012216]
Atrial Fibrillation[MeSHID:D001281]
Mitral Valve[MeSHID:D008943]
Myocardial Infarction[MeSHID:D009203]
Thromboembolism[MeSHID:D013923]
Pulmonary Embolism[MeSHID:D011655]
Collagen Diseases[MeSHID:D003095]
Transient Cerebral Ischemia[MeSHID:D002546]
Recurrence (disease attribute)[MeSHID:D012008]
Thrombosis[MeSHID:D013927]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 26.68 approved unknown
click here to return to the previous page